Figure 1. Structure of an antibody-toxin conjugate. ADCs consist of three main components: a monoclonal antibody for specific interaction with receptors on the surface of tumor cells, a cytotoxic substance for destroying tumor cells, and a chemical linker that regulates the release of the drug, adapted from [8] (CC BY-SA 4.0).